In February 2020 amidst the Covid-19 pandemic, Pfizer CEO Albert Bourla asked his employees, “If not us, then who?” and then directed his teams to “…make the impossible possible” to create the first FDA-approved Covid-19 vaccine. Months later the Comirnaty® vaccine was a solution the world was waiting for, to save lives and support the return to “normalcy.”
But how did this pharma giant quickly pivot, adjust, manufacture and distribute billions of doses during a pandemic? Tom will review not just how the manufacturing goal was met and maintained, but also how a transformational program is raising ongoing operational standards to Pfizer Global Supply sites around the world.
At a time in economic history, when the phrase “supply chain” may receive less than positive opinions, Pfizer was named number six among the top global supply chains*, above giants like The Coca-Cola Company and Microsoft. The company’s changes have led to improved customer service levels to support patients around the world. Join us to hear about these changes firsthand. *according to Gartner Supply Chain Top 25 for 2022
Vice President, Hospital Business Unit Global Supply Chain,
You must be logged in and own this session in order to